作者
Rohit Gupta, Robert P Baughman, Steven D Nathan, Athol U Wells, Vasilis Kouranos, Esam H Alhamad, Daniel A Culver, Joseph Barney, Eva M Carmona, Francis C Cordova, Marloes Huitema, Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Surinder S Birring, Laura C Price, Stephen John Wort, Oksana A Shlobin
发表日期
2022/5/1
期刊
Respiratory Medicine
卷号
196
页码范围
106801
出版商
WB Saunders
简介
Introduction
Sarcoidosis associated pulmonary hypertension (SAPH) is a leading contributor to sarcoidosis-related mortality. The 6-min walk test (6MWT) is widely used in assessment of cardiorespiratory conditions. A reduced 6-min walk distance (6MWD) has been associated with increased mortality in SAPH. We examined patients from the Registry of Sarcoidosis Associated Pulmonary Hypertension (ReSAPH) who had performed 6MWT at enrollment to identify variables that affect 6MWD, and the prognostic value of 6MWT variables regarding death or lung transplantation.
Material and methods
ReSAPH patients with available 6MWT were included. Variables analyzed using pre-defined cutoffs included 6MWD, initial and end of test Borg dyspnea score, oxygen saturation, and heart rate at beginning, end, and after 1-min recovery, absolute change in oxygen saturation, modified distance-saturation product (mDSP …
学术搜索中的文章
R Gupta, RP Baughman, SD Nathan, AU Wells… - Respiratory Medicine, 2022